tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market
Advertisement

Crescent Biopharma (CBIO) Technical Analysis

Compare
988 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Crescent Biopharma’s (CBIO) Moving Averages Convergence Divergence (MACD) indicator is -0.34, suggesting Crescent Biopharma is a Sell.
Crescent Biopharma’s (CBIO) 20-Day exponential moving average is 11.94, while Crescent Biopharma’s (CBIO) share price is $12.54, making it a Buy.
Crescent Biopharma’s (CBIO) 50-Day exponential moving average is 12.79, while Crescent Biopharma’s (CBIO) share price is $12.54, making it a Sell.

Crescent Biopharma (CBIO) Pivot Points

Oct 18, 2025, 04:06 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.27
10.76
11.56
12.05
12.85
13.34
14.14
Fibonacci
10.76
11.26
11.56
12.05
12.55
12.85
13.34
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crescent Biopharma (CBIO) Moving Averages

Oct 18, 2025, 04:06 PM
Period
Simple
Exponential
MA5
11.36Buy
11.85Buy
MA10
11.54Buy
11.73Buy
MA20
11.96Buy
11.94Buy
MA50
12.86Sell
12.79Sell
MA100
14.05Sell
14.83Sell
MA200
19.71Sell
19.69Sell
Crescent Biopharma’s (CBIO) 10-Day exponential moving average is 11.73, while Crescent Biopharma’s (CBIO) share price is $12.54, making it a Buy.
Crescent Biopharma’s (CBIO) 100-Day exponential moving average is 14.83, while Crescent Biopharma’s (CBIO) share price is $12.54, making it a Sell.
Crescent Biopharma’s (CBIO) stock price is $12.54 and Crescent Biopharma’s (CBIO) 50-day simple moving average is 12.86, creating a Sell signal.
Crescent Biopharma’s (CBIO) stock price is $12.54 and Crescent Biopharma’s (CBIO) 100-day simple moving average is 14.05, creating a Sell signal.
Crescent Biopharma’s (CBIO) stock price is $12.54 and Crescent Biopharma’s (CBIO) 200-day simple moving average is 19.71, creating a Sell signal.

Crescent Biopharma (CBIO) Technical Indicators

Oct 18, 2025, 04:06 PM
Name
Value
Implied Action
RSI (14)
53.73
Neutral
STOCH (9,6)
80.23
Sell
STOCHRSI (14)
76.58
Neutral
MACD (12,26)
-0.34
Sell
ADX (14)
23.61
Neutral
Williams %R
-4.71
Sell
CCI (14)
39.06
Neutral
ATR (14)
0.92
-
Ultimate Oscillator
46.47
Neutral
ROC
2.03
Buy
Crescent Biopharma’s (CBIO) Relative Strength Index (RSI) is 53.73, creating a Neutral signal.
Crescent Biopharma’s (CBIO) Trend Strength Indicator (ADX) is 23.61, creating a Neutral signal.
Crescent Biopharma’s (CBIO) Commodity Channel Index (CCI) is 39.06, creating a Neutral signal.
Crescent Biopharma’s (CBIO) Price Rate of Change (ROC) is 2.03, creating a Buy signal.

FAQ

Is CBIO a Buy, Hold, or Sell?
Based on CBIO’s technical indicators, CBIO is a Hold.
    What is CBIO’s RSI (14)?
    CBIO’s RSI (14) is 53.73, which suggests CBIO is a Neutral.
      What is CBIO’s MACD?
      CBIO’s MACD is -0.34, which suggests CBIO is a Sell.
        What is CBIO’s 5-day moving average?
        CBIO’s 5-day moving average is 11.36, which suggests CBIO is a Buy.
          What is CBIO’s 20-day moving average?
          CBIO 20-day moving average is 11.96, which suggests CBIO is a Buy.
            What is CBIO’s 50-day moving average?
            CBIO’s 50-day moving average is 12.86, which suggests CBIO is a Sell.
              What is CBIO’s 200-day moving average?
              CBIO’s 200-day moving average is 19.71, which suggests CBIO is a Sell.
                What is CBIO’s Williams % R (14)?
                CBIO’s Williams % R (14) is -4.71, which suggests CBIO is a Sell.
                  What is CBIO’s CCI (14)?
                  CBIO’s CCI (14) is 39.06, which suggests CBIO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis